ARA American Renal Associates Holdings Inc.

American Renal Associates Holdings, Inc. Appoints Two New Members to Board of Directors

American Renal Associates Holdings, Inc. (NYSE: ARA) (“ARA” or the “Company”), a leading provider of outpatient dialysis services, today announced that Susanne (Susy) V. Clark and Robert H. Fish were appointed to the company’s board of directors. Mr. Fish will serve on ARA’s board of directors and as a member of the board’s audit committee.

Joseph (Joe) Carlucci, Chairman and Chief Executive Officer, remarked, “We are very pleased to expand our board of directors with two accomplished professionals who will strengthen our board and help advance ARA’s strategic priorities. I have had the opportunity to work closely with Susy Clark since Centerbridge’s investment in ARA and have been impressed with her business acumen and capital markets expertise. Robert Fish brings considerable health care services perspectives and leadership experience from a variety of health care settings to our board. We welcome them both to ARA’s board, and we look forward to their contributions to the company.”

Ms. Clark’s business and legal experience spans over 20 years. She joined Centerbridge Partners, L.P. (“Centerbridge”) in 2009 and serves as Senior Managing Director and General Counsel. Prior to joining Centerbridge, Ms. Clark has had a distinguished career serving in legal and business roles at a variety of financial services firms, including General Counsel and Chief Compliance Officer of Basso Capital Management, L.P., Deputy General Counsel of Amaranth Group Inc., and Vice President and Assistant General Counsel of Goldman Sachs Group, Inc. Ms. Clark started her career as an Associate in the New York Office of Shearman & Sterling LLP. Ms. Clark graduated with honors from Swarthmore College and received her J.D. from Columbia Law School. As a Class II member of the board, Ms. Clark will stand for election at our 2018 Annual Meeting of Shareholders.

Mr. Fish brings more than 30 years of health care services experience to the ARA board. Mr. Fish currently serves as a director and chairman of Genesis Healthcare, Inc. (NYSE: GEN) and as a director for LifeCare Health Partners, LLC. Mr. Fish has held leadership positions in a wide variety of health care services organizations, including CEO of Skilled Healthcare Group, Inc. prior to its combination with Genesis Healthcare, Inc. (“Genesis”), Managing Partner of Sonoma-Seacrest, LLC, Chairman and CEO of Genesis Health Ventures, a predecessor to Genesis, President and CEO of St. Joseph Health System, and President and CEO of Valley Care Health System. Mr. Fish’s prior board experience includes serving as chairman of REACH Medical Holdings, serving as the executive chairman of Coram, Inc., and serving as a director of NeighborCare, Inc. Mr. Fish also serves as a member of the board of directors of the St. Helena Hospital Foundation, a philanthropic organization benefiting the St. Helena Hospitals in Napa Valley. Mr. Fish holds a Bachelor of Arts in Sociology from Whittier College, and a Master’s degree in Hospital Administration from the University of California at Berkeley. The board of directors has determined that Mr. Fish qualifies as an independent director under NYSE listing standards applicable to audit committee members, and as a Class I member of the board, he will stand for election at the upcoming Annual Meeting of Shareholders on June 16, 2017.

About American Renal Associates

American Renal Associates Holdings, Inc. (NYSE: ARA) is a leading provider of outpatient dialysis services in the United States. As of December 31, 2016, ARA operated 214 dialysis clinic locations in 25 states and the District of Columbia serving approximately 14,500 patients with end stage renal disease. ARA operates exclusively through a physician partnership model, in which it partners with approximately 380 local nephrologists to develop, own and operate dialysis clinics. ARA’s Core Values emphasize taking good care of patients, providing physicians with clinical autonomy and operational support, hiring and retaining the best possible staff and providing best practices management services. For more information about American Renal Associates, visit www.americanrenal.com.

EN
19/04/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on American Renal Associates Holdings Inc.

 PRESS RELEASE

American Renal Associates Holdings, Inc. Announces Third Quarter 2020 ...

BEVERLY, Mass.--(BUSINESS WIRE)-- American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading kidney care and dialysis provider focused on partnering with local nephrologists, today announced financial and operating results for the third quarter ended September 30, 2020. Certain metrics, including those expressed on an adjusted basis, are Non-GAAP financial measures (See “Use of Non-GAAP Financial Measures” and the reconciliation tables further below). Third Quarter 2020 Highlights (all percentage changes compare Q3 2020 to Q3 2019 unless noted): Patient service operati...

 PRESS RELEASE

American Renal Associates Enters Into Definitive Agreement to be Acqui...

BEVERLY, Mass.--(BUSINESS WIRE)-- American Renal Associates Holdings, Inc. (NYSE: ARA) (“ARA” or the “Company”), a leading provider of outpatient dialysis services, today announced that it has entered into a definitive agreement to be acquired by Innovative Renal Care, LLC (“IRC”), an affiliate of Nautic Partners, LLC (“Nautic”), a middle market private equity firm, in an all-cash transaction that values the Company at an aggregate enterprise valuation of approximately $853 million excluding non-controlling interest. Under the terms of the agreement, ARA shareholders will receive $11.50 per sh...

 PRESS RELEASE

American Renal Associates Holdings, Inc. Announces Settlement of Share...

BEVERLY, Mass.--(BUSINESS WIRE)-- American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading provider of outpatient dialysis services, is pleased to announce that the Company has received preliminary approval of the settlement of a stockholder derivative action brought by Plaintiff Luke Johnson, and pending in the United States District Court for the District of New Jersey (case number No. 19-cv-15812) (the “Johnson Action”). The proposed settlement releases all claims asserted against the Company and the other named defendants in the Johnson Action without any liability o...

 PRESS RELEASE

American Renal Associates Holdings, Inc. Announces Second Quarter 2020...

BEVERLY, Mass.--(BUSINESS WIRE)-- American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading kidney care and dialysis provider focused on partnering with local nephrologists, today announced financial and operating results for the second quarter ended June 30, 2020. The Company also provided an update on its COVID-19 impact and affirmed its 2020 Adjusted EBITDA less noncontrolling interests (“Adjusted EBITDA-NCI”) Outlook. These updates are highlighted later in this release. Certain metrics, including those expressed on an adjusted basis, are Non-GAAP financial measures ...

 PRESS RELEASE

American Renal Associates Holdings, Inc. Announces Second Quarter 2020...

BEVERLY, Mass.--(BUSINESS WIRE)-- American Renal Associates Holdings, Inc. (NYSE: ARA), a leading kidney care and dialysis services provider focused on partnering with local nephrologists, announced today that it will release its second quarter 2020 earnings results after the market close on Monday, August 10, 2020, to be followed by a conference call on Tuesday, August 11, 2020 at 9:00 a.m. (Eastern Time). The conference call can be accessed live over the phone by dialing (877) 407-8029, or for international callers (201) 689-8029. A replay will be available one hour after the call and can ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch